News for '-satyanarayana-mysore'

Sales of Biocon's itolizumab surge as phase-4 clinical trials begin

Sales of Biocon's itolizumab surge as phase-4 clinical trials begin

Rediff.com6 Oct 2020

In India, itolizumab, known by the brand name Alzumab, has been priced at Rs 8,000 per vial. Most patients require four vials for Covid-19 treatment, taking the cost of the therapy to Rs 32,000.

Second Covid wave is 1.7x times faster than first wave, shows data

Second Covid wave is 1.7x times faster than first wave, shows data

Rediff.com15 Apr 2021

It has taken 51 days to reach a daily caseload of 84,000 from 11,000, as against 85 days taken in the first wave, report Abhishek Waghmare and Sohini Das.

'It is common for any virus to mutate'

'It is common for any virus to mutate'

Rediff.com22 Dec 2020

'There is no data to show this virus is more deadlier.'

Pandemic pushes up demand for CT scanners; firms gear up to meet surge

Pandemic pushes up demand for CT scanners; firms gear up to meet surge

Rediff.com4 Nov 2020

Siemens Healthineers, one of the largest manufacturers of made-in-India CT scanners, has sold 80-100 such machines in the last 45 days. The medical technology firm typically sells 250 machines in a year.

India may see wave of peaks in COVID-19 cases

India may see wave of peaks in COVID-19 cases

Rediff.com20 Jul 2020

Many experts feel the concept of a national peak is nebulous, given that the growth in case numbers is dominated by a handful of states.

In battle against COVID-19, India faces new challenges

In battle against COVID-19, India faces new challenges

Rediff.com29 May 2020

The pandemic is set to become even more challenging, with migrant workers returning home, relaxations in lockdown rules, and the approaching monsoon. However, states are looking at community participation to ramp up testing and home treatment of patients